Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Genmab A (GMAB) Return on Sales (2024 - 2025)

Historic Return on Sales for Genmab A (GMAB) over the last 2 years, with Q4 2025 value amounting to 1.09%.

  • Genmab A's Return on Sales fell 16500.0% to 1.09% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.0%, marking a year-over-year decrease of 4200.0%. This contributed to the annual value of 0.06% for FY2025, which is 4300.0% down from last year.
  • Genmab A's Return on Sales amounted to 1.09% in Q4 2025, which was down 16500.0% from 0.47% recorded in Q3 2025.
  • Genmab A's Return on Sales' 5-year high stood at 0.56% during Q4 2024, with a 5-year trough of 1.09% in Q4 2025.